November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
November 12, 2009 - Centers for Medicare & Medicaid Services' (CMS) will expand coverage of FDG-PET for the initial ...
November 12, 2009 - Positron Corp. predicts an industry wide demand for cardiac PET imaging, as a result of the Centers ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
October 30, 2009 - By using positron emission tomography (PET) researchers were to able to identify neuroinflammation ...
October 20, 2009 - 2-18F-fluoropropionic acid (18F-FPA) as a PET tracer for imaging prostate cancer has potential for ...
October 12, 20009 - Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, is ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
October 8, 2009 - Effective Jan. 1, 2010, the American College of Radiology (ACR) CT, MRI, Nuclear Medicine and PET ...
October 7, 2009 - CMS recently released to the Medicare Administrative Contractors (MACs), via transmittals 1817 and 106 ...
October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a new ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
September 30, 2009 – Positron Corp. predicts a significant rise in demand for cardiac PET in 2010 with a proposed cut in ...
September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will attend ...
September 25, 2009 - Cancer physicians and cancer care advocates applauded a bipartisan letter led by Senators Richard ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
September 23, 2009 - Siemens announced today the sixth annual “New Point of View” Preclinical Image of the Year awards ...
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd., a ...
“Our profession faces one of the most significant crises in its history,” said Michael Graham, M.D., president of the ...
September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to assess ...
September 15, 2009 - The Finance Committee in a health-overhaul bill calls for device makers to pay $40 billion in fees ...
September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is ...
September 9, 2009 - The American Society of Clinical Oncology (ASCO) has received CEO Cancer Gold Standard accreditation ...
In the pre-clinicial trial Expanding the Versatility of Cardiac PET/CT: Feasibility of Delayed Contrast Enhancement CT ...
November 18, 2009 